Description
FIDAS-3 effectively competes against S-adenosylmethionine (SAM) for MAT2A binding.FIDAS-3 has anticancer activities.FIDAS-3 is a stilbene derivative and is a potent Wnt inhibitor with an IC50 of 4.9uM for methionine S-adenosyltransferase 2A (MAT2A)